FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of general formula (I) , as well as to a method for their preparation, pharmaceutical compositions based thereon, and their application.
EFFECT: new compounds have been obtained that can be used to treat or prevent pathology for which it is necessary to inhibit the mTOR kinase.
20 cl, 4 tbl, 30 ex
Title | Year | Author | Number |
---|---|---|---|
AZABICYCLOOCTANE DERIVATIVE, PHARMACEUTICAL PREPARATIONS, METHOD FOR PROPHYLAXIS OR TREATMENT, METHODS FOR PREPARING COMPOUNDS, COMPOUNDS | 2000 |
|
RU2262505C2 |
MORPHOLINO-SUBSTITUTED DERIVATIVES OF BICYCLIC PYRIMIDINE UREA OR CARBAMATE AS MTOR INHIBITORS | 2012 |
|
RU2609208C2 |
IMIDAZOPYRAZINE OR IMIDAZODIAZEPINE DERIVATIVES, ACTIVE WITH RESPECT TO RECEPTOR CB2 | 2008 |
|
RU2540074C2 |
1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
TYPE 1 DIACYLGLYCEROL O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2497816C2 |
NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | 2013 |
|
RU2660429C2 |
NEW INDOLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2013 |
|
RU2646223C2 |
PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
Authors
Dates
2017-08-04—Published
2013-01-25—Filed